Sermorelin 5mg

Researchers investigate Sermorelin within controlled laboratory environments to examine GHRH analog structure and mechanisms. Experimental models utilize this compound to study growth hormone-releasing hormone characteristics in vitro. Controlled laboratory peptide stability studies assess compound properties under standardized experimental conditions. Scientists explore GHRH peptide structures in research settings. Laboratory personnel examine peptide behavior in experimental models designed for hormone analog research. These investigations occur exclusively in controlled research environments without clinical applications.

Sermorelin is investigated in research environments to understand GHRH analog mechanisms. This compound is studied within controlled laboratory models examining growth hormone-releasing hormone properties. Researchers explore this peptide for experimental peptide research applications in academic and institutional settings. Laboratory studies examine the compound’s structural characteristics under standardized protocols. Scientists investigate molecular properties relevant to GHRH research methodologies. All research applications remain confined to laboratory environments and experimental frameworks.

Store Sermorelin at 2-8°C for optimal stability. Storage temperature should remain consistent to maintain compound integrity. Keep the product sealed until ready for laboratory use. Laboratory handling should occur only by qualified research personnel trained in peptide research protocols. Avoid exposure to moisture, heat, and direct sunlight during storage. Use appropriate laboratory equipment when handling this research compound. Reconstitution should follow standard laboratory peptide preparation procedures using sterile techniques. Maintain proper documentation of handling and storage conditions for research records. Dispose of unused material according to institutional laboratory waste protocols.

Each batch undergoes comprehensive purity verification procedures to confirm research-grade quality. Third-party testing validates compound purity at 99%+ by HPLC analysis. Batch-to-batch consistency ensures reliable results across research protocols. Certificate of Analysis accompanies each order documenting purity verification results. Internal quality assurance standards maintain strict compound specifications. Testing procedures verify molecular weight, purity percentage, amino acid sequence, and compound identity. Research-grade supply positioning ensures suitability for controlled laboratory investigations. Quality control documentation supports institutional research compliance requirements.

• CAS: 86168-78-7
• Chemical Formula: C₁₄₉H₂₄₆N₄₄O₄₂S
• Molecular Weight: 3357.9 g/mol
• Peptide Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂
• Synonyms: GHRH (1-29)
• Shelf life: 24 months from the manufacturing date.

Sermorelin is a synthetic GHRH analog peptide compound produced for research applications. A GHRH analog is a modified version of growth hormone-releasing hormone. This peptide consists of 29 amino acids representing the active fragment of natural GHRH. The compound is designated as GHRH(1-29) in research literature. Scientists study GHRH analogs to understand hormone structure-activity relationships. This synthetic peptide origin ensures batch-to-batch consistency for research protocols. The compound represents the bioactive N-terminal portion of the natural hormone. Researchers examine this peptide’s properties within controlled laboratory conditions without therapeutic context.

This synthetic research peptide formulation provides laboratories with a standardized GHRH analog compound for experimental studies. The compact 5mg format supports controlled research applications in qualified laboratory settings. Each batch undergoes rigorous purity verification to ensure consistency across research protocols. High-purity formulation meets research-grade standards for GHRH peptide investigations. Secure packaging protects compound integrity during storage and transport. Discreet shipment ensures confidential delivery to research facilities and institutional laboratories.

Sermorelin represents the first 29 amino acids of the full-length 44-amino acid GHRH molecule. This N-terminal fragment contains the complete biological activity in experimental systems. Researchers use this analog to study which portions of the hormone structure are essential for receptor binding and activation.

Research applications include GHRH receptor binding studies, structure-activity relationship investigations, hormone analog stability characterization, and comparative analyses with other growth hormone-releasing peptides. Specific applications depend on research objectives in peptide hormone chemistry. Research teams determine protocols based on their investigation goals.

Sermorelin should be stored at 2-8°C in light-protected conditions following institutional laboratory standards. After reconstitution, the peptide should be stored at 2-8°C and used according to institutional protocols. Researchers should establish appropriate stability testing procedures for their specific experimental applications.